Provista Diagnostics Receives $6,046,254 New Funding Round

  • Feed Type
  • Date
    8/4/2015
  • Company Name
    Provista Diagnostics
  • Mailing Address
    160 Varick Street New York, NY 10013 USA
  • Company Description
    Provista Diagnostics, Inc. develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes.
  • Website
    http://www.provistadx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,046,254
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy